CN102670569A - Method for preparing absorbable minocyline drug diaphragm - Google Patents

Method for preparing absorbable minocyline drug diaphragm Download PDF

Info

Publication number
CN102670569A
CN102670569A CN2012101358842A CN201210135884A CN102670569A CN 102670569 A CN102670569 A CN 102670569A CN 2012101358842 A CN2012101358842 A CN 2012101358842A CN 201210135884 A CN201210135884 A CN 201210135884A CN 102670569 A CN102670569 A CN 102670569A
Authority
CN
China
Prior art keywords
diaphragm
minocyline
drug
minocycline
absorbable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012101358842A
Other languages
Chinese (zh)
Inventor
李全利
曹颖
祝小鹏
徐晓华
刘魏
徐燕
周健
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Medical University
Original Assignee
Anhui Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Medical University filed Critical Anhui Medical University
Priority to CN2012101358842A priority Critical patent/CN102670569A/en
Publication of CN102670569A publication Critical patent/CN102670569A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The invention relates to a method for preparing an absorbable minocyline drug diaphragm, which comprises the step of operating that 1 hydrochloric acid minocyline powder is dissolved into distilled water to obtain hydrochloric acid minocyline solution; 2 gelatin is added into the hydrochloric acid minocyline solution in water bath at 40 DEG C to be uniformly mechanically stirred away from light; 3 glycerin is further added in the water bath at 40 DEG C to go on to be uniformly stirred and obtain faint yellow viscous liquid; 4 the faint yellow viscous liquid is paved on a plate to be made into a diaphragm in room temperature, and a gel diaphragm which has a thickness of 0.5-0.6mm is obtained after solidifying; and 5 the gel diaphragm is frozen and dried to obtain the absorbable minocyline drug diaphragm. The method for preparing the absorbable minocyline drug diaphragm is simple in operation, excellent in controlling, environmental friendly and high in yield. The method for preparing the absorbable minocyline drug diaphragm is convenient to be applied in clinical, compared with similar products abroad, the absorbable minocyline drug diaphragm has excellent cost performance, and does not have obvious difference in effects of clinical application.

Description

A kind of method for preparing of absorbability minocycline medicine film
Technical field
The invention belongs to bio-pharmaceutical engineer technology domain, relate to the method for preparing of local application in the clinical oral materia medica.
Background technology
Periodontitis is a kind of by the cause a disease pathological changes of a kind of progressive irreversible destruction periodontal support tissue that dominant microflora causes of periodontal.Its sickness rate is high, and is ascendant trend gradually, and along with the increase at age, its sickness rate also increases gradually.Along with the aging of society, the ratio of periodontal in the clinical outpatient service of stomatology is also increasingly high.Drug therapy is occupied critical role as a kind of important foundation Therapeutic Method of periodontal in the treatment of periodontal disease.The oral systemic administration method that waits often causes the periodontal local drug concentration low, bad complication, and cause certain waste.Therefore,, can overcome the shortcoming that is administered systemically, become the topmost administering mode of present periodontal disease Drug therapy at pathological changes periodontal topical.Using antibacterials in the periodontal disease therapeutic at present mainly is the imidazoles antibacterials, like metronidazole, tinidazole, ornidazole; Tetracyclines.The example hydrochloric acid tetracycline, minocycline etc.The slow release formulation that periodontal uses mainly contains at present; Home-made metronidazole rod (starch fiber carrier), its storage time in periodontal pocket is short; The present domestic use of imported product mainly be the minocycline ointment of commodity Palio by name, its clinical application effect is good, and is easy to operate, but price is more expensive.
Minocycline not only has sensitivity to the dominant microflora of periodontitis, and can suppress the decomposition of connective tissue, suppresses the absorption of bone.Therefore, be a kind of comparatively ideal selection at the local use of periodontitis minocycline preparation.The Drug therapy of periodontitis is occupied bigger clinical technology proportion at China's basic hospital, and therefore, the periodontal topical pharmaceutical formulation of development of new has great demand.
Summary of the invention
In order to solve the more expensive problem of periodontitis Drug therapy Chinese medicine price, the present invention provides a kind of method for preparing of good, absorbability minocycline medicine film that product has good cost performance simple to operate, controlled.
Concrete operations step of the present invention is following:
1. diaphragm-operated method for preparing of absorbability minocycline medicine is characterized in that:
Raw materials used with the amount as follows:
Minocycline hydrochloride 0.2~0.5 gram
Gelatin 0.5~1 gram
2 milliliters of glycerol
8 milliliters of distilled water;
The preparation manipulation step is following:
(1). 0.2~0.5 gram minocycline hydrochloride is dissolved in 8 ml distilled waters, obtains minocycline hydrochloride solution;
(2). in minocycline hydrochloride solution, add 0.5~1 gram gelatin, water-bath under 40 ℃ of conditions of temperature, lucifuge, mechanical agitation are even;
(3). add 2 milliliters of glycerol again, water-bath under 40 ℃ of conditions of temperature continues to stir, and gets light yellow viscous liquid;
(4). with light yellow viscous liquid, bed board system film at room temperature solidifies that to obtain thickness be the gel diaphragm of 0.5~0.6mm;
(5). with the lyophilization of gel diaphragm, obtain absorbability minocycline diaphragm, cut apart, pack;
Aforesaid operations all carries out under the condition of lucifuge.
Useful technique effect of the present invention is embodied in the following aspects:
1, method for preparing of the present invention is simple to operate, and is controlled good, environmental friendliness, and output is high;
2, method for preparing clinical practice of the present invention is convenient, belongs to the non-invasive therapy technology, is easy to promote;
3, medicine diaphragm of the present invention will soften in vivo, have good fitness with the periodontal pocket environment;
4, the new material of the present invention's acquisition is compared with external like product, has good cost performance, the clinical application effect no significant difference.
The specific embodiment
Below in conjunction with embodiment the present invention is done to describe further.
Embodiment 1:
The diaphragm-operated method for preparing of absorbability minocycline medicine comprises following operating procedure:
Raw materials used with the amount as follows:
Minocycline hydrochloride (purity 99%, Wuhan Yuancheng Technology Development Co., Ltd., China) 0.5 gram
Gelatin (Sigm-Aldrich company, the U.S.) 1 gram
2 milliliters of glycerol
8 milliliters of distilled water;
(1). 0.5 gram minocycline hydrochloride is dissolved in 8 ml distilled waters, obtains minocycline hydrochloride solution;
(2). in minocycline hydrochloride solution, add 1 gram gelatin, 40 ℃ of water-baths, lucifuge, mechanical agitation are even;
(3). add 2 milliliters of glycerol again, 40 ℃ of water-baths continue to stir, and obtain light yellow viscous liquid;
(4). with light yellow viscous liquid, at room temperature bed board system film solidifies the gel diaphragm that obtains the about 0.5mm of thickness;
(5). with the lyophilization of gel diaphragm, obtain absorbability minocycline medicine diaphragm, cut apart, pack;
Aforesaid operations all carries out under the condition of lucifuge;
(6) C 60Sterilization, subsequent use.
Illustrate the clinical practice of absorbability minocycline medicine film below, range of application of the present invention is not limited thereto.
Give an example 1: be applied to the treatment of chronic periodontitis
Method for using:
Behind the periodontitis cacodontia cleaning tooth body, at a distance from wetting, dry up gingival sulcus.Above-mentioned minocycline diaphragm is placed in the periodontal pocket.
Give an example 2: be applied to the treatment of acute pericoronitis of the wisdom tooth
Acute pericoronitis of the wisdom tooth, at first after the flushing of conventional 3% hydrogen peroxide, the tooth body is placed into above-mentioned minocycline diaphragm in the hat week bag at a distance from wetting, dry up gingival sulcus.
Embodiment 2:
The method for preparing of absorbability minocycline medicine film comprises following operating procedure:
Raw materials used with the amount as follows:
Minocycline hydrochloride 0.2 gram
Gelatin 0.5 gram
2 milliliters of glycerol
8 milliliters of distilled water;
(1). 0.2 gram minocycline hydrochloride is dissolved in 8 ml distilled waters, obtains minocycline hydrochloride solution;
(2). in minocycline hydrochloride solution, add 0.5 gram gelatin, 40 ℃ of water-baths, lucifuge, mechanical agitation are even;
(3). add 2 milliliters of glycerol again, 40 ℃ of water-baths continue to stir, and obtain light yellow viscous liquid;
(4). with light yellow viscous liquid, at room temperature bed board system film solidifies the gel diaphragm that obtains the about 0.5mm of thickness;
(5). with the lyophilization of gel diaphragm, obtain absorbability minocycline medicine diaphragm, cut apart, pack;
Aforesaid operations all carries out under the condition of lucifuge;
(6) C 60Sterilization, subsequent use.

Claims (1)

1. diaphragm-operated method for preparing of absorbability minocycline medicine is characterized in that:
Raw materials used with the amount as follows:
Minocycline hydrochloride 0.2~0.5 gram
Gelatin 0.5~1 gram
2 milliliters of glycerol
8 milliliters of distilled water;
The preparation manipulation step is following:
(1). 0.2~0.5 gram minocycline hydrochloride is dissolved in 8 ml distilled waters, obtains minocycline hydrochloride solution;
(2). in minocycline hydrochloride solution, add 0.5~1 gram gelatin, water-bath under 40 ℃ of conditions of temperature, lucifuge, mechanical agitation are even;
(3). add 2 milliliters of glycerol again, water-bath under 40 ℃ of conditions of temperature continues to stir, and gets light yellow viscous liquid;
(4). with light yellow viscous liquid, bed board system film at room temperature solidifies that to obtain thickness be the gel diaphragm of 0.5~0.6mm;
(5). with the lyophilization of gel diaphragm, obtain absorbability minocycline diaphragm, cut apart, pack;
Aforesaid operations all carries out under the condition of lucifuge.
CN2012101358842A 2012-05-04 2012-05-04 Method for preparing absorbable minocyline drug diaphragm Pending CN102670569A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101358842A CN102670569A (en) 2012-05-04 2012-05-04 Method for preparing absorbable minocyline drug diaphragm

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101358842A CN102670569A (en) 2012-05-04 2012-05-04 Method for preparing absorbable minocyline drug diaphragm

Publications (1)

Publication Number Publication Date
CN102670569A true CN102670569A (en) 2012-09-19

Family

ID=46803564

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101358842A Pending CN102670569A (en) 2012-05-04 2012-05-04 Method for preparing absorbable minocyline drug diaphragm

Country Status (1)

Country Link
CN (1) CN102670569A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023082A (en) * 1986-05-18 1991-06-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Sustained-release pharmaceutical compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023082A (en) * 1986-05-18 1991-06-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Sustained-release pharmaceutical compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
姜大川等: "新型牙周药剂治疗慢性牙周炎的临床观察", 《安徽医科大学学报》, vol. 45, no. 5, 31 October 2010 (2010-10-31), pages 671 - 672 *
王姹等: "米诺环素凝胶辅助治疗牙周炎的临床观察", 《安徽医科大学学报》, vol. 47, no. 1, 31 January 2012 (2012-01-31), pages 63 - 66 *

Similar Documents

Publication Publication Date Title
CN105581992A (en) Preparation method and application of starch/ferulic acid colon-targeted controlled-release carrier matrix tablet
CN103193772A (en) Preparation method and application of substituted aryl propionic berberine ion-pair compound
CN111012737A (en) Flurbiprofen sodium gel and preparation method thereof
TW201029651A (en) Anti-inflammatory compounds and compositions thereof
CN102743333A (en) Levetiracetam oral liquid and preparation method of levetiracetam oral liquid
AU642309B2 (en) Complexes containing S(+) phenyl alkane acids and amino sugars
JPS5896036A (en) Manufacture of novel naphthalene derivative
JP4750691B2 (en) Anti-inflammatory treatment
CN101474144A (en) Tetracaine hydrochloride lipidosome gel and preparation method thereof
CN102670569A (en) Method for preparing absorbable minocyline drug diaphragm
CN102579390A (en) Ibuprofen timing release three-layer tablet drug composition and method for preparing same
CN104447770A (en) Asenapine compound
JP2017534635A (en) Crystalline polymorph of revaprazan hydrochloride and its preparation method
CN102283926A (en) Preparation technology and production method for novel integrated dosage form of liver fire-purging and stomach-regulating pill
CN101249063A (en) Calciparine/sodium salt nano oral preparation and preparation technique thereof
CN101978945A (en) Ibuprofen medicinal composition
CN102283937A (en) Technology for preparing novel integrated dosage form of stomach-clearing powder and production method thereof
US20040265299A1 (en) Oral pharmaceutical formulation containing active carbon and use of the same
CN103893767A (en) Ibuprofen medicine composition with stable quality
CN102697703A (en) Piroxicam gel preparation and preparation method thereof
CN118021746B (en) Preparation method and application of orally disintegrating tablet for treating dental ulcer
CN1895269A (en) Compound iodine oral solution quantitative drops and preparation thereof
CN103028095A (en) Preparation technology and production method of integrated new dosage form of dry ginger and Radix aconiti lateralis preparata decoction
CN102283990A (en) Technology for preparing novel sweet wormwood and turtle shell decoction integrated preparation
RU2012111354A (en) NEW CRYSTALLINE HYDRATES OF FLUORGYCLOSIDES CONTAINING THEIR PHARMACEUTICAL DRUGS AND THEIR USE

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120919